Q2 2026 13F · SEC CIK 1385702
Mak Capital One LLC
Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $713.8M
- Reported positions
- 17
- Top holdings a year, 3 yrs
- +25.4%
- Assets under management
- $2.0B
Mak Capital One LLC is a hedge fund that reported 17 positions worth $713.8M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Agilysys Inc (AGYS, 17.5%), Grupo Financiero Galicia S.a (GGAL, 10.4%), Acadia Healthcare Company in (ACHC, 10.1%). A portfolio copying its top holdings returned 25.4% a year over the last 3 years, against 19.0% for the S&P 500.
Mak Capital One LLC holdings all 17 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| AGYSAgilysys Inc | 17.5% | +0.0% | $124.6M |
| GGALGrupo Financiero Galicia S.a | 10.4% | +4.0% | $74.3M |
| ACHCAcadia Healthcare Company in | 10.1% | +0.0% | $71.8M |
| QUREUniqure NV | 8.0% | +179.2% | $56.7M |
| SKYChampion Homes Inc | 7.8% | -50.7% | $55.7M |
| AUTLAutolus Therapeutics PLC | 7.5% | +0.0% | $53.8M |
| CLPTClearpoint Neuro Inc | 5.9% | +24.9% | $42.4M |
| SUPVGrupo Supervielle S.a. | 5.8% | +0.0% | $41.1M |
| CAICaris Life Sciences Inc | 4.8% | — | $34.5M |
| ANNXAnnexon Inc | 4.7% | +24.1% | $33.5M |
| FLDMStandard Biotools Inc | 3.3% | +10.1% | $23.7M |
| LODEComstock Inc | 3.0% | -10.0% | $21.6M |
| CYRXCryoport Inc | 2.8% | -10.3% | $20.1M |
| HNSTHonest Co Inc | 2.4% | +0.0% | $17.5M |
| CVECenovus Energy Inc | 2.3% | +0.0% | $16.2M |
| PESIPerma-Fix Environmental Svcs | 2.1% | +12.4% | $14.8M |
| YTRAYatra Online Inc. | 1.6% | +0.0% | $11.5M |
What Mak Capital One LLC bought and sold in Q2 2026, against Q1 2026.
New positions
- CAI Caris Life Sciences Inc4.8% of 13F
Added to
- QURE Uniqure NV+179.2% shares
- CLPT Clearpoint Neuro Inc+24.9% shares
- ANNX Annexon Inc+24.1% shares
- PESI Perma-Fix Environmental Svcs+12.4% shares
- FLDM Standard Biotools Inc+10.1% shares
Reduced
- SKY Champion Homes Inc-50.7% shares
- CYRX Cryoport Inc-10.3% shares
- LODE Comstock Inc-10.0% shares
Sold out
- COUR Coursera Incwas 5.4%
- UDMY Udemy Incwas 2.8%
- PLX Protalix Biotherapeutics Incwas 1.3%
- FVRR Fiverr Intl Ltdwas 0.1%
- SGMO Sangamo Therapeutics Incwas 0.0%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +62.4% /yr
- S&P 500 +14.9%
- 3 years
- +25.4% /yr
- S&P 500 +19.0%
- 5 years
- +15.0% /yr
- S&P 500 +10.4%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $713.8M | 17 |
| Q1 2026 | $604.3M | 21 |
| Q4 2025 | $743.2M | 21 |
| Q3 2025 | $501.3M | 12 |
| Q2 2025 | $566.7M | 14 |
| Q1 2025 | $470.2M | 8 |
| Q4 2024 | $522.3M | 8 |
| Q3 2024 | $489.4M | 10 |
| Q2 2024 | $417.8M | 9 |
| Q1 2024 | $504.4M | 10 |
| Q4 2023 | $540.9M | 7 |
| Q3 2023 | $539.5M | 11 |
Questions about Mak Capital One LLC's portfolio
What stocks does Mak Capital One LLC own?
Mak Capital One LLC's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 17 positions worth $713.8M. The largest are Agilysys Inc (AGYS) at 17.5%, Grupo Financiero Galicia S.a (GGAL) at 10.4%, Acadia Healthcare Company in (ACHC) at 10.1%, Uniqure NV (QURE) at 8.0% and Champion Homes Inc (SKY) at 7.8%.
What did Mak Capital One LLC buy last quarter?
In Q2 2026, Mak Capital One LLC added a new position in Caris Life Sciences Inc (CAI), Uniqure NV (QURE) (+179.2% shares), Clearpoint Neuro Inc (CLPT) (+24.9% shares) and Annexon Inc (ANNX) (+24.1% shares), compared with its Q1 2026 filing.
What did Mak Capital One LLC sell last quarter?
In Q2 2026, Mak Capital One LLC sold all of Coursera Inc (COUR), sold all of Udemy Inc (UDMY), sold all of Protalix Biotherapeutics Inc (PLX), sold all of Fiverr Intl Ltd (FVRR), sold all of Sangamo Therapeutics Inc (SGMO), Champion Homes Inc (SKY) (-50.7% shares), Cryoport Inc (CYRX) (-10.3% shares) and Comstock Inc (LODE) (-10.0% shares), compared with its Q1 2026 filing.
How has Mak Capital One LLC's portfolio performed?
A portfolio copying Mak Capital One LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +25.4% a year over the last 3 years, against +19.0% for the S&P 500. Over 1 year: +62.4% against +14.9%. Over 5 years: +15.0% a year against +10.4%.
When is Mak Capital One LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Mak Capital One LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Mak Capital One LLC manage?
Mak Capital One LLC reported $2.0B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $713.8M.